{"id":80359,"date":"2023-11-21T18:43:00","date_gmt":"2023-11-21T21:43:00","guid":{"rendered":"https:\/\/bluestudio.estadao.com.br\/agencia-de-comunicacao\/releases\/releases-geral\/nyxoah-to-participate-in-the-piper-sandler-35th-annual-healthcare-conference\/"},"modified":"2023-11-21T18:43:00","modified_gmt":"2023-11-21T21:43:00","slug":"nyxoah-to-participate-in-the-piper-sandler-35th-annual-healthcare-conference","status":"publish","type":"post","link":"https:\/\/bluestudio.estadao.com.br\/agencia-de-comunicacao\/releases\/releases-geral\/nyxoah-to-participate-in-the-piper-sandler-35th-annual-healthcare-conference\/","title":{"rendered":"Nyxoah to Participate in the Piper Sandler 35th Annual Healthcare Conference"},"content":{"rendered":"<p><b>Nyxoah<\/b><\/p>\n<p align=\"center\"><strong>Nyxoah to Participate in the Piper Sandler 35<\/strong><sup><strong>th<\/strong><\/sup><strong> Annual Healthcare Conference<\/strong><\/p>\n<p align=\"justify\"><strong>Mont-Saint-Guibert, Belgium  November 21, 2023, 10:30pm CET \/ 4:30pm ET  Nyxoah SA (Euronext Brussels\/Nasdaq: NYXH)<\/strong> (Nyxoah or the Company), a medical technology company focused on the development and commercialization of innovative solutions to treat Obstructive Sleep Apnea (OSA), today announced that the Company will participate in the Piper Sandler 35th Annual Healthcare Conference, which takes place November 28  30, 2023 in New York. <\/p>\n<p align=\"justify\">Olivier Taelman, Nyxoahs Chief Executive Officer, will be participating in a Fireside Chat on Wednesday, November 29, 2023, at 2:30pm ET. A <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=2VjiJdXuB15n1cS9gqyIakoNtV6XyZ4r6ScCyafDTpQWzXBcM1FJ1y8epo0xjZIdycBhqqQAdqwVc_xwFZcmrTD8WdUPRqy8ugzEMNCP0cNpvoT2g1E0btuJd5nCB1Opa4BR6ztTb1h6jGnPWRlINg==\" rel=\"nofollow noopener\" target=\"_blank\">webcast<\/a> of the presentation will be available on the <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=0beUMoMqcWzQyHdW9VNwvG4NSN31Q7yQ24Nqm8yCPp5kxaVlFMYsW_TJNVPheF6Ir1675wRQZF-GZTwkOmVl__3edyCtgN35wMep3xVrpSI=\" rel=\"nofollow noopener\" target=\"_blank\">Events section<\/a> of Nyxoahs Investor Relations website. The Company will also be available for 1&#215;1 meetings with institutional investors attending the event.<\/p>\n<p align=\"justify\">Nyxoahs Investor Presentation can be accessed on the <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=GXeSFGmyicfcXhDQyCpdhc0P4RZfRjgY6iJb1Bp7yfwhyFgfZoIA8R8HshlyKlr6MUKqDjKwS5e85aeXj1ZUnmKMw0SE7k0fyX18DouPJUQVPhZFPseB-AMNDccE4RT4mavPaI251JX92WyJq3K6vA==\" rel=\"nofollow noopener\" target=\"_blank\">Shareholder Information<\/a> section of the Companys Investor Relations page.<\/p>\n<p align=\"justify\"><strong>About Nyxoah<\/strong><br \/>Nyxoah is a medical technology company focused on the development and commercialization of innovative solutions to treat Obstructive Sleep Apnea (OSA). Nyxoahs lead solution is the Genio\u00ae system, a patient-centered, leadless and battery-free hypoglossal neurostimulation therapy for OSA, the worlds most common sleep disordered breathing condition that is associated with increased mortality risk and cardiovascular comorbidities. Nyxoah is driven by the vision that OSA patients should enjoy restful nights and feel enabled to live their life to its fullest.\u00a0<\/p>\n<p align=\"justify\">Following the successful completion of the BLAST OSA study, the Genio\u00ae system received its European CE Mark in 2019. Nyxoah completed two successful IPOs: on Euronext Brussels in September 2020 and NASDAQ in July 2021. Following the positive outcomes of the BETTER SLEEP study, Nyxoah received CE mark approval for the expansion of its therapeutic indications to Complete Concentric Collapse (CCC) patients, currently contraindicated in competitors therapy. Additionally, the Company is currently conducting the DREAM IDE pivotal study for FDA and U.S. commercialization approval.<\/p>\n<p align=\"justify\">For more information, please visit <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=Z_zMjHDYdckjtk36VkBoDH5QC9kmiqi9d4BD9yFlqUT6ovNnGxpjzMjdSImWwsDfhdMDKDffQXHSGIAdDauSZ7dKUBk2tktJ5pVPwW70Dd0=\" rel=\"nofollow noopener\" target=\"_blank\">http:\/\/www.nyxoah.com\/<\/a>.<\/p>\n<p align=\"justify\"><strong>Caution <\/strong> CE marked since 2019. Investigational device in the United States. Limited by U.S. federal law to investigational use in the United States.<\/p>\n<p align=\"justify\"><strong>Contact:<\/strong><br \/><strong>Nyxoah<\/strong><br \/>David DeMartino, Chief Strategy Officer<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=p7IAJ9rU8P0fhr7mAK32lMDLmfkl7rnO8rmiXrk7bQZnE0haSFHdfjj1iRNuTcM1tTpdTlyTixLozJn8UViQIJHB4BPUqYGMHT3hgOgPywRFc5H-wmi4g4EzSjP9O1zw\" rel=\"nofollow noopener\" target=\"_blank\">david.demartino@nyxoah.com <\/a><br \/>+1 310 310 1313<\/p>\n<p \/>\n<p id=\"gnw_attachments_section-header\">\n <strong>Attachment<\/strong>\n<\/p>\n<ul id=\"gnw_attachments_section-items\">\n<li>\n  <a target=\"_blank\" href=\"https:\/\/ml-eu.globenewswire.com\/Resource\/Download\/f8afa65b-d7b2-4667-b05e-3ff09b251a37\" rel=\"noopener\">ENGLISH_Nyxoah to Participate in the Piper Sandler 35th Annual Healthcare Conference<\/a>\n<\/li>\n<\/ul>\n<p><img decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=MTAwMDkwMDU1MSM0MDE2OTA5NjAjMjE5NzYyNw==\" \/> <br \/><img decoding=\"async\" src=\"https:\/\/ml-eu.globenewswire.com\/media\/NzU4YzUwZmYtZWZiZi00YjIyLWI5YzgtMTBhOThjYWEyYzAwLTEyMDkxODA=\/tiny\/Nyxoah.png\" \/><br \/>\n<a href=\"https:\/\/www.globenewswire.com\/NewsRoom\/AttachmentNg\/e2fa6f25-aeb6-4638-a872-0484a355ccc2\"><img loading=\"lazy\" decoding=\"async\" src=\"https:\/\/ml-eu.globenewswire.com\/media\/e2fa6f25-aeb6-4638-a872-0484a355ccc2\/small\/nyxoah-rgb01-jpg.jpg\" border=\"0\" width=\"150\" height=\"51\" alt=\"Primary Logo\" \/><\/a><\/p>\n<p>A <b>OESP<\/b> nao e(sao) responsavel(is) por erros, incorrecoes, atrasos ou quaisquer decisoes tomadas por seus clientes com base nos Conteudos ora disponibilizados, bem como tais Conteudos nao representam a opiniao da <b>OESP<\/b> e sao de inteira responsabilidade da <b>GlobeNewswire<\/b><\/p>\n","protected":false},"excerpt":{"rendered":"Nyxoah Nyxoah to Participate in the Piper Sandler 35th Annual Healthcare Conference Mont-Saint-Guibert, Belgium November 21, 2023, 10:30pm CET \/ 4:30pm ET Nyxoah SA (Euronext Brussels\/Nasdaq: NYXH)","protected":false},"author":1,"featured_media":80360,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"inline_featured_image":false,"_monsterinsights_skip_tracking":false,"_monsterinsights_sitenote_active":false,"_monsterinsights_sitenote_note":"","_monsterinsights_sitenote_category":0,"footnotes":""},"categories":[34],"tags":[],"class_list":["post-80359","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-releases-geral"],"acf":[],"_links":{"self":[{"href":"https:\/\/bluestudio.estadao.com.br\/agencia-de-comunicacao\/wp-json\/wp\/v2\/posts\/80359","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/bluestudio.estadao.com.br\/agencia-de-comunicacao\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/bluestudio.estadao.com.br\/agencia-de-comunicacao\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/bluestudio.estadao.com.br\/agencia-de-comunicacao\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/bluestudio.estadao.com.br\/agencia-de-comunicacao\/wp-json\/wp\/v2\/comments?post=80359"}],"version-history":[{"count":0,"href":"https:\/\/bluestudio.estadao.com.br\/agencia-de-comunicacao\/wp-json\/wp\/v2\/posts\/80359\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/bluestudio.estadao.com.br\/agencia-de-comunicacao\/wp-json\/wp\/v2\/media\/80360"}],"wp:attachment":[{"href":"https:\/\/bluestudio.estadao.com.br\/agencia-de-comunicacao\/wp-json\/wp\/v2\/media?parent=80359"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/bluestudio.estadao.com.br\/agencia-de-comunicacao\/wp-json\/wp\/v2\/categories?post=80359"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/bluestudio.estadao.com.br\/agencia-de-comunicacao\/wp-json\/wp\/v2\/tags?post=80359"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}